Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer
- DOI
- 10.1016/j.clcc.2026.04.003
- Published
- 2026-09
- Container
- Clinical Colorectal Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clcc.2026.04.003,
title = {Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer},
author = {Lisa Salvatore and Marwan Fakih and Yasutoshi Kuboki and David S. Hong and Dominik Paul Modest and Julien Taieb and Timothy Jay Price and Chiara Cremolini and Istvan Matyas Majer and Marko Rehn and Emily Chan and Ziyan Chen and Qui Tran and Filippo Pietrantonio},
year = {2026},
journal = {Clinical Colorectal Cancer},
doi = {10.1016/j.clcc.2026.04.003},
url = {https://doi.org/10.1016/j.clcc.2026.04.003}
}RIS
TY - JOUR TI - Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer AU - Lisa Salvatore AU - Marwan Fakih AU - Yasutoshi Kuboki AU - David S. Hong AU - Dominik Paul Modest AU - Julien Taieb AU - Timothy Jay Price AU - Chiara Cremolini AU - Istvan Matyas Majer AU - Marko Rehn AU - Emily Chan AU - Ziyan Chen AU - Qui Tran AU - Filippo Pietrantonio PY - 2026 JO - Clinical Colorectal Cancer DO - 10.1016/j.clcc.2026.04.003 UR - https://doi.org/10.1016/j.clcc.2026.04.003 ER -
APA
Salvatore, L., Fakih, M., Kuboki, Y., Hong, D. S., Modest, D. P., Taieb, J., Price, T. J., Cremolini, C., Majer, I. M., Rehn, M., Chan, E., Chen, Z., Tran, Q., & Pietrantonio, F. (2026). Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2026.04.003
Source records
- crossref · retrieved 2026-09-25T16:40:55.044Z